Innovation Gateway executed a testing agreement with a golf course for experimental bermudagrass lines developed by Brian Schwartz, department of crop and soil sciences.
UGA startup Lectenz® Bio was awarded a SBIR Phase II grant from NIH to further develop its high-specificity affinity reagents.
Lectenz® Bio is also seeking a Lab Manager and a Research Scientist to join their team in Athens to develop novel technologies and services in glycoscience that advance research and clinical applications.
Innovation Gateway and Abcam entered into a non-exclusive agreement for a versatile monoclonal antibody developed in the lab of Richard Meagher, department of genetics.
Innovation Gateway executed a non-exclusive license agreement for a blueberry cultivar developed by Scott NeSmith, department of horticulture.
An Innovation Gateway staff member presented on intellectual property and licensing to students enrolled in the “Introduction to Bioinformatics” class offered by UGA’s Institute of Bioinformatics.
Innovation Gateway was an exhibitor at the Southeast Regional Fruit and Vegetable Conference in Savannah, GA.
Kerafast launched five new products originating from research developed in the laboratories of Mark Brown and Michael Strand, department of entomology.
Innovation Gateway met with company representatives interested in a research collaboration with UGA to produce and process a potential new crop in Georgia.
The Spring 2018 UGA I-Corps cohort launched and features six teams interested in transitioning their innovations into the marketplace.
Innovation Gateway and Kerafast entered into a series of license agreements for multiple enzymes produced by UGA’s BioExpression and Fermentation Facility.
